Joel M. Zinberg, a visiting scholar at the American Enterprise Institute, a practicing surgeon at Mount Sinai Hospital, and an associate clinical professor of surgery at the Icahn School of Medicine, thinks so.
The Stanford Prevention Research Center, in a comprehensive review of 39 screening tests for 19 diseases, found that reductions in death due to screening are rare. Nevertheless, patients routinely undergo overly intensive, low-value tests. About half of women who had a hysterectomy and no longer have a cervix, for example, are still getting PAP tests for cervical cancer screening. Despite the absence of evidence supporting screening in these older populations, cervical and breast cancer screenings are performed in 38 percent and 50 percent, respectively, of women over 80; and more than 50 percent of men over 75 report that their physicians continue to recommend PSA screening. It is nearly certain that these older men and women will die of some cause other than occult breast, cervical, or prostate cancer. One study found that significant numbers of Medicare patients with a known advanced cancer and a short life expectancy were still being screened for other cancers.
His entire article can be read here.